Yang Huan, Wang Haichao, Czura Christopher J, Tracey Kevin J
Laboratory of Biomedical Science, Institute for Medical Research at North Shore-Long Island Jewish System, Manhasset, NY 11030, USA.
J Leukoc Biol. 2005 Jul;78(1):1-8. doi: 10.1189/jlb.1104648. Epub 2005 Feb 25.
High mobility group box 1 (HMGB1) is a highly conserved, ubiquitous protein present in the nuclei and cytoplasm of nearly all cell types. We recently discovered that HMGB1 is secreted into the extracellular milieu and acts as a proinflammatory cytokine. Administration of HMGB1 to normal animals causes inflammatory responses, including fever, weight loss and anorexia, acute lung injury, epithelial barrier dysfunction, arthritis, and death. Anti-HMGB1 treatment, with antibodies or specific antagonists, rescues mice from lethal endotoxemia or sepsis and ameliorates the severity of collagen-induced arthritis and endotoxin-induced lung injury. Here, we give an abridged review of the cytokine activity of HMGB1, its secretion and release into the extracellular milieu, the putative signal transduction pathways, including interaction with cell-surface receptors and intracellular signaling, and its role in several inflammatory diseases. Finally, the therapeutic potential of blocking HMGB1 in the treatment of inflammatory diseases is discussed.
高迁移率族蛋白B1(HMGB1)是一种高度保守、普遍存在的蛋白质,几乎存在于所有细胞类型的细胞核和细胞质中。我们最近发现,HMGB1会分泌到细胞外环境中,并作为一种促炎细胞因子发挥作用。向正常动物体内注射HMGB1会引发炎症反应,包括发热、体重减轻和厌食、急性肺损伤、上皮屏障功能障碍、关节炎以及死亡。用抗体或特异性拮抗剂进行抗HMGB1治疗,可使小鼠免于致命性内毒素血症或败血症,并减轻胶原诱导的关节炎和内毒素诱导的肺损伤的严重程度。在此,我们对HMGB1的细胞因子活性、其分泌并释放到细胞外环境的过程、假定的信号转导途径(包括与细胞表面受体的相互作用和细胞内信号传导)及其在几种炎症性疾病中的作用进行简要综述。最后,讨论了阻断HMGB1在炎症性疾病治疗中的潜在治疗价值。